{"id":"W2154955762","doi":"10.1007/s10227-006-0103-1","title":"Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches","year":2005,"lang":"en","type":"review","venue":"Journal of Cutaneous Medicine and Surgery","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Guenther Dermatology Research Centre; University of Calgary; University of Manitoba; Sunnybrook Health Science Centre; Probity Medical Research; University of British Columbia; University Health Network; Dalhousie University; University of Toronto; Université Laval; Lynde Centre for Dermatology; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Psoriasis; Etanercept; Infliximab; Efalizumab; Intensive care medicine; Biologic Agents; Clinical trial; Position paper; Disease; Ustekinumab; Plaque psoriasis; Dermatology; Pathology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02727072,0.001413874,0.002016402,0.003433619,0.003413948,0.004975438,0.007226784,0.02077556,0.01282486],"category_scores_gemma":[0.0779841,0.001086086,0.004476284,0.002665264,0.002897475,0.005698435,0.004480855,0.02707677,0.009674853],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005244215,"about_ca_system_score_gemma":0.0297017,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01420115,"about_ca_topic_score_gemma":0.04229841,"domain_scores_codex":[0.9689236,0.01329714,0.005036214,0.0009263465,0.01018146,0.001635224],"domain_scores_gemma":[0.9229822,0.02058513,0.006066113,0.0023729,0.03845342,0.009540441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008322967,0.0005228446,0.001246618,0.001118321,0.00008929257,0.0006117019,0.0006369329,0.0007691862,0.0005530822,0.006501971,0.833029,0.1548378],"study_design_scores_gemma":[0.0004577318,0.0001503517,0.002976367,0.007646002,0.0002113205,0.000825393,0.000898317,0.0007415581,0.0003496426,0.01293259,0.9726769,0.0001339173],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.001358587,0.01545288,0.0198788,0.8874282,0.0109157,0.002389678,0.0004939641,0.0008296811,0.06125251],"genre_scores_gemma":[0.01572671,0.04086519,0.2464335,0.6545622,0.01015492,0.004810927,0.00183119,0.000350309,0.02526514],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.02727072,"threshold_uncertainty_score":0.1442231,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1425839899393587,"score_gpt":0.3278647980418575,"score_spread":0.1852808081024988,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}